• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管中的免疫系统和微生物组:对理解炎症性疾病的意义。

Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.

机构信息

Department of Biomedicine, University of Basel, Switzerland.

Clarunis - University Center for Gastrointestinal and Liver Diseases Basel, Switzerland.

出版信息

FEBS J. 2022 Aug;289(16):4758-4772. doi: 10.1111/febs.16103. Epub 2021 Jul 13.

DOI:10.1111/febs.16103
PMID:34213831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9542113/
Abstract

The gastrointestinal tract is the largest compartment of the body's immune system exposed to microorganisms, structural components and metabolites, antigens derived from the diet, and pathogens. Most studies have focused on immune responses in the stomach, the small intestine, and the colon, but the esophagus has remained an understudied anatomic immune segment. Here, we discuss the esophagus' anatomical and physiological distinctions that may account for inflammatory esophageal diseases.

摘要

胃肠道是人体免疫系统最大的一个腔室,它暴露于微生物、结构成分和代谢物、源自饮食的抗原以及病原体。大多数研究都集中在胃、小肠和结肠的免疫反应上,但食管一直是一个研究不足的解剖免疫部位。在这里,我们讨论了食管的解剖和生理学差异,这些差异可能导致了炎症性食管疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4c/9542113/a6b210d37c35/FEBS-289-4758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4c/9542113/e65662f35b21/FEBS-289-4758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4c/9542113/a6b210d37c35/FEBS-289-4758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4c/9542113/e65662f35b21/FEBS-289-4758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4c/9542113/a6b210d37c35/FEBS-289-4758-g001.jpg

相似文献

1
Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.食管中的免疫系统和微生物组:对理解炎症性疾病的意义。
FEBS J. 2022 Aug;289(16):4758-4772. doi: 10.1111/febs.16103. Epub 2021 Jul 13.
2
The Esophageal Microbiome in Health and Disease.健康与疾病状态下的食管微生物群
Curr Gastroenterol Rep. 2018 Aug 1;20(8):39. doi: 10.1007/s11894-018-0642-9.
3
Comparative anatomy, physiology, and mechanisms of disease production of the esophagus, stomach, and small intestine.食管、胃和小肠的比较解剖学、生理学及疾病发生机制。
Toxicol Pathol. 2014 Jan;42(1):54-66. doi: 10.1177/0192623313518113.
4
[Eosinophilic gastroenteritis in the esophagus, stomach, and small intestine in a patient with a choking feeling in the esophagus].[一名有食管哽噎感患者的食管、胃和小肠嗜酸性粒细胞性胃肠炎]
Nihon Shokakibyo Gakkai Zasshi. 2007 May;104(5):660-5.
5
Regional specialization within the intestinal immune system.肠道免疫系统的区域专业化。
Nat Rev Immunol. 2014 Oct;14(10):667-85. doi: 10.1038/nri3738. Epub 2014 Sep 19.
6
Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System.肠道微生物组在健康和疾病中的影响:与宿主免疫系统的共同进化。
Curr Top Microbiol Immunol. 2019;421:303-318. doi: 10.1007/978-3-030-15138-6_12.
7
Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.巴雷特食管和食管腺癌中食管微生物群的改变。
World J Gastroenterol. 2019 May 14;25(18):2149-2161. doi: 10.3748/wjg.v25.i18.2149.
8
Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment.环境和生活方式对大小肠疾病的影响:对治疗的启示。
Dig Dis. 2011;29(2):249-54. doi: 10.1159/000323930. Epub 2011 Jul 5.
9
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies.食管微生物组在嗜酸性粒细胞性食管炎中的作用及不同治疗方法引起的变化。
Sci Rep. 2021 Mar 29;11(1):7113. doi: 10.1038/s41598-021-86464-z.
10
[The state and role of esophagus, stomach, intestinal microbiota in patients with ulcer disease, chronic gastritis, esophagitis.].[溃疡病、慢性胃炎、食管炎患者食管、胃、肠道微生物群的状态及作用。]
Klin Lab Diagn. 2020;65(1):42-49. doi: 10.18821/0869-2084-2020-65-1-42-49.

引用本文的文献

1
Mitigation of radiation-induced esophageal fibrosis by macrophage-targeted phosphatidylserine-containing liposomes with partial PEGylation.通过部分聚乙二醇化的靶向巨噬细胞的含磷脂酰丝氨酸脂质体减轻辐射诱导的食管纤维化
Bioact Mater. 2025 Jun 18;52:574-587. doi: 10.1016/j.bioactmat.2025.06.021. eCollection 2025 Oct.
2
The oesophagus as an immune organ.作为免疫器官的食管。
Nat Rev Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1038/s41575-025-01086-4.
3
Eosinophilic Esophagitis Pathogenesis: All Clear?嗜酸性食管炎的发病机制:真相大白了吗?

本文引用的文献

1
Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes.复制和荟萃分析确定了许多嗜酸性粒细胞性食管炎的风险基因。
J Allergy Clin Immunol. 2021 Jan;147(1):255-266. doi: 10.1016/j.jaci.2020.10.018. Epub 2020 Oct 23.
2
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.布地奈德口腔崩解片在嗜酸性粒细胞性食管炎患者的随机、安慰剂对照试验中维持缓解。
Gastroenterology. 2020 Nov;159(5):1672-1685.e5. doi: 10.1053/j.gastro.2020.07.039. Epub 2020 Jul 25.
3
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.
Inflamm Intest Dis. 2025 May 8;10(1):135-150. doi: 10.1159/000546241. eCollection 2025 Jan-Dec.
4
Eosinophilic Esophagitis without Eosinophils: Do You Want to Mock Me?无嗜酸性粒细胞的嗜酸性食管炎:你想嘲笑我吗?
Inflamm Intest Dis. 2025 Apr 29;10(1):126-134. doi: 10.1159/000546069. eCollection 2025 Jan-Dec.
5
The epithelial barrier theory and its associated diseases.上皮屏障理论及其相关疾病。
Allergy. 2024 Dec;79(12):3192-3237. doi: 10.1111/all.16318. Epub 2024 Oct 7.
6
The oral microbiome and oral and upper gastrointestinal diseases.口腔微生物群与口腔及上消化道疾病
J Oral Microbiol. 2024 Jun 3;16(1):2355823. doi: 10.1080/20002297.2024.2355823. eCollection 2024.
7
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis.胃食管反流病(GORD)发病机制中的黏膜神经免疫机制。
J Gastroenterol. 2024 Mar;59(3):165-178. doi: 10.1007/s00535-023-02065-9. Epub 2024 Jan 14.
8
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned.反流性食管炎中的食管黏膜抵抗力:我们目前所了解的情况及仍有待了解的内容。
Diagnostics (Basel). 2023 Aug 12;13(16):2664. doi: 10.3390/diagnostics13162664.
9
Eosinophilic Esophagitis beyond Eosinophils - an Emerging Phenomenon Overlapping with Eosinophilic Esophagitis: Collegium Internationale Allergologicum (CIA) Update 2023.嗜酸性粒细胞性食管炎超越嗜酸性粒细胞 - 与嗜酸性粒细胞性食管炎重叠的新兴现象:国际变态反应学会(CIA)2023 年更新。
Int Arch Allergy Immunol. 2023;184(5):411-420. doi: 10.1159/000529910. Epub 2023 Mar 27.
10
Ion channel regulation of gut immunity.肠道免疫的离子通道调节。
J Gen Physiol. 2023 Feb 6;155(2). doi: 10.1085/jgp.202113042. Epub 2022 Dec 2.
激肽释放酶5和蛋白酶激活受体2在嗜酸性食管炎中的功能作用。
Sci Transl Med. 2020 May 27;12(545). doi: 10.1126/scitranslmed.aaz7773.
4
Calcium-sensing receptor deletion in the mouse esophagus alters barrier function.钙敏感受体敲除小鼠食管改变屏障功能。
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G144-G161. doi: 10.1152/ajpgi.00021.2019. Epub 2019 Nov 11.
5
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.度普利尤单抗在成人活性嗜酸性粒细胞性食管炎的 2 期随机试验中的疗效。
Gastroenterology. 2020 Jan;158(1):111-122.e10. doi: 10.1053/j.gastro.2019.09.042. Epub 2019 Oct 5.
6
Microbiota of the Oropharynx and Endoscope Compared to the Esophagus.口咽和内镜与食管微生物群的比较。
Sci Rep. 2019 Jul 15;9(1):10201. doi: 10.1038/s41598-019-46747-y.
7
Epithelial HIF-1α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis.上皮细胞 HIF-1α/紧密连接蛋白 1 轴调节嗜酸性粒细胞性食管炎的屏障功能障碍。
J Clin Invest. 2019 Jul 2;129(8):3224-3235. doi: 10.1172/JCI126744.
8
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.布地奈德口腔崩解片作为嗜酸细胞性食管炎诱导治疗的疗效:一项随机安慰剂对照试验。
Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.
9
Microbial network disturbances in relapsing refractory Crohn's disease.复发缓解型和难治性克罗恩病中的微生物网络紊乱
Nat Med. 2019 Feb;25(2):323-336. doi: 10.1038/s41591-018-0308-z. Epub 2019 Jan 21.
10
Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.三维类器官揭示食管和口咽鳞状细胞癌细胞的治疗抵抗性。
Cell Mol Gastroenterol Hepatol. 2018 Sep 14;7(1):73-91. doi: 10.1016/j.jcmgh.2018.09.003. eCollection 2019.